The discount drug program, which started in September 2006, now will cover 361 prescriptions representing different formulations of 157 generic drugs.
Ads by Google
President Bush signed into law a bill that will expand FDA oversight of prescription drug safety and reauthorize the Prescription Drug User Fee Act.
More than 90 percent of Medicare beneficiaries in a stand-alone Part D prescription drug plan (PDP) will have access to at least one plan in 2008 with premiums lower than they are paying this year.
Body Positive holds a nationally recognized clinical trial site used by pharmaceutical companies to test antiretroviral drugs.
FDA announced its intention to take enforcement action against companies marketing unapproved prescription drug products containing hydrocodone, a narcotic widely used to treat pain and suppress coughs.
Pharmacy groups are lobbying Congress to ask for a delay of a rule that will require prescriptions for Medicaid beneficiaries to be written on tamper-resistant pads.
FDA has granted 510(k) clearance for ISTO Technologies's InQu for use as a bone graft extender in the spine and as a bone graft substitute in the extremities and pelvis.
Annual inflation for prescription drug over the past 12 months totaled 1%, a decrease from 4.4% in 2005 and the lowest rate in the past 30 years, according to the Consumer Price Index released on Wednesday by the Bureau of Labor Statistics at the Department of Labor, the New York Times reports (Saul , New York Times, 9/21).
Senate approved a compromise bill that would expand FDA oversight of prescription drug safety and reauthorize the Prescription Drug User Fee Act.
American University's Center for Congressional and Presidential Studies will announce results from a national survey assessing public views on safety of prescription medicines.
Perrigo Company has received approval from FDA to manufacture and market Ciclopirox Topical Solution, 8% (Nail Lacquer).
Replidyne's antibacterial candidate REP3123 is shown to in hibit growth and prevent spore-forming of the Gram-positive Clostridium difficile bacterium.
FDA has granted Orphan Drug Designation to Immtech Pharmaceuticals's pafuramidine for treating Human African Trypanosomiasis.
A bill would expand FDA oversight of prescription drug safety and reauthorize the Prescription Drug User Fee Act.
Targanta Therapeutics highlights the in vitro activity and in vivo efficacy of its proprietary prodrugs in osteomyelitis models.
New Jersey task force will consider whether the state should require pharmaceutical companies and medical device makers to disclose gifts they give to physicians.
House Democrats esumed negotiations to reconcile differences between the House and Senate versions of legislation that would reauthorize the Prescription Drug User Fee Act.
sNDA for lubiprostone of Sucampo Pharmaceuticals for the treatment of irritable bowel syndrome with constipation has been accepted for review by FDA.
FDA cleared for marketing a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin.
Delays in reimbursements from Medicare prescription drug plans for medications dispensed have prompted a number of community pharmacies to close.
FDA employees might receive layoff notices as early as the end of this week in the event that lawmakers do not finalize a bill to reauthorize the Prescription Drug User Fee Act.
Congress , industry experts and advocacy groups continue to disagree on how best to create a system for releasing clinical trial data to the public.
Medicaid directors seek a one-year delay of a rule that will require pharmacists to reject paper prescriptions for Medicaid beneficiaries not written on tamper-resistant paper.
Patients and their doctors could choose whether to use an experimental drug now, wait for more drug information, or rely on only FDA-approved treatments.
Use of electronic prescribing in Medicare could prevent as many as 1.9 million medication errors and save the program as much as $29 billon over the next 10 years.
Three-month extension of the Prescription Drug User Fee Act until Congress can resolve differences in House and Senate versions of a bill to reauthorize the law.
U.S. adults in 2004 purchased more than $9 billion -- the most spent on any prescription drug -- of the anti-cholesterol medication Lipitor, followed by $4.7 billion on the anti-cholesterol treatment Zocor, according to a survey released on Wednesday by the Agency for Healthcare Research and Quality, Reuters/Los Angeles Times reports. In addition, the survey found that adults in 2004 used $4.2 billion of the ulcer medication Nexium and $2.4 billion on the ulcer treatment Prevacid.
Researchers raise concerns over suggestions that drug makers could supply information on medicines to patients, as part of a proposal to modify the current ban on direct to consumer advertising in Europe.
Seniors enrolled in Medicare plans that charge higher copayments for brand name or non-preferred medications could spend less and fill fewer prescriptions.